Patents Assigned to ALACRITY PATIENT SERVICES, INC.
  • Method and apparatus for monitoring development of medication induced febrile neutropenia
    Patent number: 11045149
    Abstract: Systems and methods for home monitoring and detection of febrile neutropenia in a patient are provided. The system includes a photoplethysmographic sensor for sensing photoplethysmographic signals of the patient, and one or more blood borne parameter sensors for sensing parameters in the patient's blood. A febrile neutropenia monitoring application receives information sensed by the photoplethysmography sensor and the one or more blood borne parameter sensors and determines, based on the received information, the presence or deterioration of febrile neutropenia.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: June 29, 2021
    Assignee: ALACRITY PATIENT SERVICES, INC.
    Inventor: David Berz
  • Method and apparatus for monitoring development of medication induced febrile neutropenia
    Patent number: 10314549
    Abstract: Systems and methods for home monitoring and detection of febrile neutropenia in a patient are provided. The system includes a photoplethysmographic sensor for sensing photoplethysmographic signals of the patient, and one or more blood borne parameter sensors for sensing parameters in the patient's blood. A febrile neutropenia monitoring application receives information sensed by the photoplethysmography sensor and the one or more blood borne parameter sensors and determines, based on the received information, the presence or deterioration of febrile neutropenia.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: June 11, 2019
    Assignee: ALACRITY PATIENT SERVICES, INC.
    Inventor: David Berz